logo
Anger management improves with age In women, study says

Anger management improves with age In women, study says

Miami Herald02-07-2025
July 2 (UPI) -- Remember your sweet-hearted grandmother, who never seemed out of sorts no matter what nonsense landed in her lap?
That's a skill, and it improves during a person's lifespan, a new study says.
Women get better at managing their anger as they age, starting in middle-age, researchers reported Wednesday in the journal Menopause.
That doesn't mean they're less angry. Researchers found that as women got older, they were more prone to anger and their anger became more intense, results show.
But women also became less likely to express their anger or act with hostility, researchers found.
'These findings are consistent with research on emotion regulation efforts during aging, such that efforts to control anger increase along with experiences of anger,' concluded the research team led by Nancy Fugate Woods of the University of Washington School of Nursing in Seattle.
For the study, researchers analyzed data from 271 women taking part in the Seattle Midlife Women's Health Study, a long-term research project that started in the early 1990s.
As part of the project, participants filled out a questionnaire related to their anger and hostility levels up to four or five times over the years.
Results showed that as women aged, they became more adept at managing anger even though they felt it more acutely.
Researchers said this might be because women feel more generativity - a sense of positively impacting the world by caring for others, particularly future generations - as they go through middle age and menopause.
'Implying greater emotional complexity among older adults, some of these changes may be seen in midlife and contribute to a sense of integration and maturity, supporting the development of generativity with aging,' researchers wrote.
Women also might become more tactical with their anger, expressing it in ways that are more positive and constructive to improve relationships, researchers said. Women who use anger in a positive way tend to feel better empowerment and self-regard.
More research is needed on women's anger in the context of everyday life, to provide more information on emotion regulation and anger management strategies, researchers said.
'The mental health side of the menopause transition can have a significant effect on a woman's personal and professional life,' Dr. Monica Christmas, associate medical director for The Menopause Society, said in a news release.
'It is well recognized that fluctuations in serum hormone concentrations during the postpartum period, as well as monthly fluctuations in reproductive-aged women corresponding with their menstrual cycles and during perimenopause, can result in severe mood swings associated with anger and hostility,' continued Christmas, who was not involved in the study.
'Educating women about the possibility of mood changes during these vulnerable windows and actively managing symptoms can have a profound effect on overall quality of life and health,' she said.
More information
The American Psychological Association has more on anger management.
Copyright © 2025 HealthDay. All rights reserved.
Copyright 2025 UPI News Corporation. All Rights Reserved.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Girl, 9. dies after incident in Hersheypark's wave pool
Girl, 9. dies after incident in Hersheypark's wave pool

UPI

time7 hours ago

  • UPI

Girl, 9. dies after incident in Hersheypark's wave pool

July 25 (UPI) -- A 9-year-old girl died after being in distress at Hersheypark's wave pool near Pennsylvania's state capital of Harrisburg. The incident occurred Thursday at The Boardwalk water park, which also includes slides and a lazy river. The Shore wave pool is 378,000 gallons, the largest in the state, and is up to 6 feet deep. Hershey Enterainment & Resorts Company didn't give details on what happened. "From the moment our lifeguard team recognized that a child was in distress, they performed an immediate rescue, followed by continuous, coordinated life-saving efforts by our lifeguards, on-site first responders and medical personnel," CEO John Lawn said in a message. The girl was taken to Milton S. Hershey Medical Center, "where despite everyone's tireless efforts, the child did not recover," Lawn said. Authorities did not identify her. In an updated statement Friday, the park said the wave pool within The Boardwalk will remain closed that day "out of respect for the family and deep appreciation of our team members who worked so valiantly in their efforts to save the life of the guest." Ten lifeguards were dedicated to the wave pool at the time of the incident, the park said. Also, complimentary life vests were available. On Thursday, Lawn said park employees were investigating the incident. "The safety of our guests has always been our highest priority," he said. "In the coming days, we will conduct a thorough internal review and cooperate with authorities." The park was founded by Milton S. Hershey in 1927 "as leisure grounds for employees of Hersehy's Chocolate Factory," according to the park's website. The 121-acre amusement park includes 15 roller-coasters. It is open from Memorial Day to Labor Day. "To every family who visits Hersheypark, please know this: your safety and well-being drive each decision we make," Lawn said. "We will thoroughly investigate this tragedy and honor the memory of this young guest by continuing our focus on ensuring the safety of our guests at Hershepark."

Wisconsin Lt. Gov. Sara Rodriguez launches gubernatorial bid
Wisconsin Lt. Gov. Sara Rodriguez launches gubernatorial bid

UPI

time8 hours ago

  • UPI

Wisconsin Lt. Gov. Sara Rodriguez launches gubernatorial bid

Wisconsin Lt. Gov. Sara Rodriguez is running for governor, the former emergency room nurse confirmed Friday. Photo courtesy of Governor of Wisconsin's office July 25 (UPI) -- Wisconsin Lt. Gov. Sara Rodriguez is running for governor, the former emergency room nurse confirmed Friday. "I'm used to being on my feet and getting right to the point, so let's go. First, I have an announcement. I'm running for governor," Rodriguez announced in a video released Friday, her 50th birthday. Rodriguez joins the Democratic primary field to replace Gov. Tony Evers, D-Wis. Evers, 73, announced in a video Thursday he would not seek re-election in November when he will turn 74. Evers has been the Governor of Wisconsin for six years and in public service for 50 years. Rodriguez is the first big name to enter the race to replace Evers. Milwaukee County Executive David Crowley confirmed Thursday to Spectrum News 1 Wisconsin that he plans to run. Former Wisconsin Lt. Gov. Mandela Barnes posted a photo of himself with Evers on X Thursday, thanking him for his service. Barnes served as lieutenant governor during Evers' first term and has hinted at a run for the office. Rodriguez previously worked in the emergency department of Baltimore's Mercy Medical Center. She later took a job at the U.S. Centers for Disease Control and Prevention between 2004 and 2006 before returning to Wisconsin. Increasing salaries for public teachers and expanding Medicaid access are among the promises Rodriguez makes in the video. "Look, we've got a real shot at flipping the state Legislature and with a Democratic governor, we can finally expand Medicaid and boost our healthcare workforce," Rodriguez says in the video, that also touches on her family's working-class roots in Wisconsin. "With a Democratic governor, we can finally expand Medicaid and boost our healthcare workforce, strengthen our farms, unions, and small businesses, fund our public schools and give teachers the raise they've earned. That's the right path."

Bayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to Menopause
Bayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to Menopause

Yahoo

time9 hours ago

  • Yahoo

Bayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to Menopause

WHIPPANY, N.J., July 25, 2025--(BUSINESS WIRE)--Bayer today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinzanetant is the first neurokinin 1 and neurokinin 3 receptor antagonist in late-stage clinical development for the hormone-free treatment of moderate to severe vasomotor symptoms (VMS) due to menopause. The FDA has determined additional time is needed for a full review of the NDA submission, including information provided to support the application. The extension to the Prescription Drug User Fee Act (PDUFA) review period is up to 90 days. The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence. "We are confident in the potential of elinzanetant to provide meaningful clinical benefit to women pending regulatory approval," said Yesmean Wahdan, M.D., Senior Vice President and Head of Medical Affairs, North America, Pharmaceuticals. "We continue to work with the FDA to make this treatment available for women in menopause with moderate to severe hot flashes. Despite the universal experience of menopause, social stigma and misinformation persist, leaving many women to suffer without treatment and support. It's critical we advance innovation and education in menopause so women can work with their healthcare provider to determine the best option for them." The NDA is based on the positive results from the OASIS 1, 2 and 3 Phase III studies evaluating the efficacy and safety of the investigational compound elinzanetant versus placebo. Results from OASIS 1 and 2 were published in August 2024 in The Journal of the American Medical Association (JAMA). Detailed results of the Phase III study OASIS 3 providing supporting efficacy and additional long-term safety data were presented at The Menopause Society (TMS) annual meeting in September 2024. In the last 30 days, elinzanetant was approved under the brand name Lynkuet™ in the United Kingdom and Canada. Submissions for marketing authorizations for elinzanetant are also ongoing in the EU and other markets around the world. About Women's Healthcare at BayerWomen's Health is in Bayer's DNA. As a global leader in women's healthcare, Bayer has a long-standing commitment to delivering science for a better life by advancing a portfolio of innovative treatments. Bayer offers a wide range of effective short- and long-acting birth control methods as well as therapies for menopause management and gynecological diseases. Bayer is also focusing on innovative options to address the unmet medical needs of women worldwide and to broadening treatment choices such as in menopause. Additionally, Bayer intends to provide 100 million women per year in low- and middle- income countries by 2030 with access to family planning by funding multi-stakeholder aid programs for capacity building and by ensuring the supply of affordable modern contraceptives. This is part of the comprehensive sustainability measures and commitments from 2020 onwards and in line with the Sustainable Development Goals of the United Nations. About BayerBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to Find more information at Follow us on Facebook: Follow us on X: @BayerPharma Forward-Looking StatementsThis release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. View source version on Contacts Media Contact: Colleen Murphy+1 Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store